Wed, Apr 16, 2014, 10:02 AM EDT - U.S. Markets close in 5 hrs 58 mins

Recent

% | $
Quotes you view appear here for quick access.

Elan Corporation, plc Message Board

peatruck 6 posts  |  Last Activity: Mar 26, 2014 1:51 PM Member since: Mar 7, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Cory Asimov quoted on Comet 1

    by wilderguide Mar 26, 2014 12:56 PM
    peatruck peatruck Mar 26, 2014 1:51 PM Flag

    what do you all think about this part---
    "Further, this interim look has a somewhat negative read-through to the final outcome on a relative basis given other pivotal trial in CRPC (e.g. Zytiga, Xtandi, Xofigo) were stopped early for efficacy."
    I'm guessing this might be cause for the huge drop, if these other treatments got trial stopped early, why not Cabo?

  • Reply to

    just listened to the cc

    by bjlikey Mar 12, 2014 11:15 AM
    peatruck peatruck Mar 12, 2014 12:33 PM Flag

    yea makes me think about what happened with AFFY and AMGN, check out the divergence there....I dunno as someone said "can't fight city hall". Seems like greed and fear always win.

  • Reply to

    AH CC

    by cincinatti_krud37 Mar 12, 2014 12:18 PM
    peatruck peatruck Mar 12, 2014 12:27 PM Flag

    its canceled, from a.m. pr

  • Reply to

    when is earnings?

    by alexismonroe38 Mar 12, 2014 11:27 AM
    peatruck peatruck Mar 12, 2014 11:33 AM Flag

    they just going to release a 10K....only cc was todays'

  • peatruck by peatruck Mar 6, 2014 4:58 PM Flag

    anyone care to comment on what the potential might be for FATE.

    Latest PR:
    Fate Therapeutics announced the publication of an article in the journal Stem Cell Reports by Fate scientists demonstrating high-throughput derivation of human induced pluripotent stem cells, or hiPSCs, that exhibit characteristics necessary for therapeutic application. The publication describes the use of the company's hiPSC platform, consisting of stage-specific cell culture systems, to enable rapid, parallel derivation of hiPSC clones and their subsequent expansion as transgene-free, single cells in culture. The Company's proprietary combinations of small molecule modulators, which include ROCK, GSK3 and MEK pathway inhibitors, used in the culture systems were found to be critical in promoting characteristics of the ground state of pluripotency including pluripotent culture stability, homogeneity and survival.

  • Reply to

    Am I Looking for a Pony?

    by icprecipice Feb 21, 2014 10:12 AM
    peatruck peatruck Feb 21, 2014 10:22 AM Flag

    nice allegory....
    I was noticing they emphasized how year end cash will be above 200M. Subtract cash now with burn for year, the pony scenario.

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.